Correlation of Immunogenicity and Reactogenicity of BNT162b2 and CoronaVac SARS-CoV-2 Vaccines

COVID-19 infection is a global health issue, and vaccination is the main strategy to control this pandemic. In this study, 189 participants received BNT162b2 or CoronaVac vaccine, and 133 of them recorded adverse events (AEs) daily for 4 weeks after vaccination. Their neutralizing antibody against S...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ruiqi, Leung, Ka-Yi, Liu, Danlei, Fan, Yujing, Lu, Lu, Chan, Pui-Chun, To, Kelvin Kai-Wang, Chen, Honglin, Yuen, Kwok-Yung, Chan, Kwok-Hung, Hung, Ivan Fan-Ngai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044926/
https://www.ncbi.nlm.nih.gov/pubmed/35285250
http://dx.doi.org/10.1128/msphere.00915-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044926/
https://www.ncbi.nlm.nih.gov/pubmed/35285250
http://dx.doi.org/10.1128/msphere.00915-21

Ejemplares similares